Foxconn and Taiwan’s leading medical centers are deploying NVIDIA-powered special agent workforces to scale the region’s transition to AI‑driven health systems.
Agentic AI represents a new hospital operating system that is adaptive, orchestrated and built to scale clinical expertise, extending Taiwan’s healthcare workforce capacity to serve the population’s growing demands.
Specialized agents are domain-specific, always-on AI systems that reason, plan and act across clinical and operational workflows within both digital and physical spaces.
Digital agents act inside systems, handling clinical reasoning, documentation and care coordination. Physical agents, including robots and intelligent devices, operate on hospital floors, managing logistics, monitoring and procedural support.
Under the Taiwan government’s “Healthy Taiwan” initiative, the region has committed $1.5 billion to build a sovereign, regulated AI-native health system spanning clinical hospitals, academic institutions and technology companies.
Foxconn will serve as the ecosystem integrator connecting government programs, hospitals, device makers and software companies to deploy real-world clinical AI at scale.
“The next era of healthcare is being powered by agentic AI — teams of digital and physical AI agents working alongside clinicians,” said Kimberly Powell, VP of healthcare at NVIDIA.
“Together with Foxconn and Taiwan’s leading medical centers, NVIDIA is accelerating the deployment of AI infrastructure that helps clinical teams, improves hospital efficiency and creates a model for health systems around the world,” said Powell.
Just as a clinical team gathers specialists with different areas of expertise to tackle complex cases, Foxconn’s CoDoctor platform brings together a coordinated team of specialized AI agents — focused on cardiovascular care, oncology, ophthalmology and more — to help clinicians reason through difficult diagnoses, manage documentation and orchestrate care across departments.
New agents within CoDoctor AI include ECG AI Agent, an AI-based EKG screening system that helps hospitals triage patients more efficiently; Corovia AI Agent, an AI-assisted solution that automatically reconstructs the heart and coronary arteries in 3D, reducing a two-hour clinical workflow to just one minute; and Endovia AI Agent, an AI-powered colonoscopy solution that supports real-time lesion detection and AI-assisted clinical workflows with millisecond-level edge inference.
Foxconn also introduced CoDoClaw, which advances CoDoctor AI from standalone AI tools into a multi-agent orchestration platform capable of coordinating AI agents across breast cancer screening, ECG analysis, fundus imaging and coronary artery analysis through a unified clinical interface.
These agents are being deployed across Taiwan’s major medical centers in areas including ECG screening for cardiac conditions, cancer subtype classification, surgical planning and real-time diagnostic support during procedures such as colonoscopy.
Foxconn’s Nurabot — a nursing collaborative robot powered by NVIDIA’s physical AI stack — completed field validation last year at Taichung Veterans General Hospital and has since moved beyond the pilot phase toward broader multisite deployment.
Nurabot is now being gradually introduced into additional hospitals, including Taipei Veterans General Hospital and Tungs’ Taichung MetroHarbor Hospital, as well as long-term care settings and overseas nursing education institutions.
By handling transport and logistics tasks, Nurabot frees an estimated two to three hours per day for frontline nurses to focus on direct patient care. Foxconn is also piloting NVIDIA NemoClaw and NVIDIA physical AI technologies in future Nurabot deployments to enhance intelligent collaboration and clinical workflow support, as well as accelerate the path from simulation to care.
“Foxconn is building the AI infrastructure and clinical platforms to connect hospitals, medical devices and software innovators across Taiwan,” said Barry Chiang, president of B group and Digital Health at Foxconn.
“With NVIDIA technologies across accelerated computing, simulation, edge AI and robotics, we are helping healthcare providers move from proof of concept to scalable, safe deployments that can improve care delivery,” said Chiang.
With 85 FDA- or TFDA-cleared medical AI solutions and every major medical center engaged in AI research or clinical trials, Taiwan is demonstrating how a strong commitment to AI-native healthcare can move from vision to measurable reality.
A majority of Taiwan’s medical centers now operate mature AI systems in their daily workflows. Active deployments span Chang Gung Memorial Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, MacKay Memorial Hospital, National Taiwan University Hospital, Taichung Veterans General Hospital, Taipei Veterans General Hospital and other leading care sites — a network handling more than 14 million patient encounters annually.
